Nancy A. Phillips, M.D., and Gloria A. Bachmann, M.D.
Dr. Phillips is Clinical Assistant Professor and Dr. Bachmann is Professor, Department of Obstetrics and Gynecology, and Professor of Medicine, Interim Chair of Obstetrics/Gynecolgy, Associate Dean for Women's Health and Chief of the OB/GYN Service at Robert Wood Johnson University Hospital, and Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ.
Within the past 12 months, Dr. Phillips reports no commercial conflicts of interest and Dr. Bachmann has received grant/research support and been a consultant to Shionogi, Inc.
Albert Einstein College of Medicine, CCME staff, and interMDnet staff have nothing to disclose.
This activity is certified for women’s health, primary care (internal medicine, family practice and gynecology), endocrinology and for all HCPs interested in the treatment of patients with VVA. This CME activity has been peer-reviewed by Judi Chervenak, M.D., Associate Professor of Obtetrics & Gynecology and Women’s Health, Albert Einstein College of Medicine, Montefiore Medical Center, Bronx, New York.
This activity is made possible by an unrestricted educational grant from Novo Nordisk
Estimated time to complete:
Albert Einstein College of Medicine – Montefiore Medical Center designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
In support of improving patient care, this activity has been planned and implemented by Albert Einstein College of Medicine-Montefiore Medical Center and InterMDnet. Albert Einstein College of Medicine – Montefiore Medical Center is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Upon completion of this Cyberounds®
, you should be able to:
- Discuss the physiology of menopausal symptoms including risk factors and associated comorbidities
- Discuss the data emerging from recent clinical trials of prospective VVA therapies/strategies including safety, efficacy and side effects
- Discuss the management of VVA, particularly with respect to overcoming medical professional and patient barriers to diagnosis and treatment.